Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. DFTX
7. APGE
8. LLY
9. RGNX
10. LCO

Go back to Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
(NASDAQ: EVAX) Delayed: 3.32 +0.27 (8.85%)
Previous Close $3.05    52 Week High $ 
Open $3.14    52 Week Low $ 
Day High $3.32    P/E N/A 
Day Low $3.02    EPS $ 
Volume 18,333